Global Cancer Oncology Testing Industry

Global Cancer Oncology Testing Industry Research & Trends Analysis Report

Global Cancer Oncology Testing Industry

Global Cancer Oncology Testing Industry Research & Trends Analysis Report


Cancer Oncology Testing Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.


Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Market IntelliX Research, the global market for Cancer Oncology Testing should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Cancer Oncology Testing market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Cancer Oncology Testing market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Fluorescence In Situ Hybridization segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospitals has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Cancer Oncology Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Cancer Oncology Testing. Report Highlights:

(1) Global Cancer Oncology Testing market size (value),history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Cancer Oncology Testing market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Cancer Oncology Testing market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Cancer Oncology Testing segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Cancer Oncology Testing segment by type and by application and regional segment by type and by application.

(6) Cancer Oncology Testing industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Fluorescence In Situ Hybridization

Polymerase Chain Reaction

Microarray Technology

Serum Proteomics

Nucleic Acid Sequencing

Market segment by application, can be divided into

Hospitals

Speciality Clinics

Research Institutes

Diagnostics Laboratories

Biopharmaceutical Companies

Market segment by players, this report covers

Devyser

Agendia

Illumina

Personal Genome Diagnostics

Veracyte

Pacific Biosciences of California

Qiagen

Agilent Technologies

Natera

Bio Rad Laboratories

Myriad Genetics

1 Market Overview

1.1 Product Overview and Scope of Cancer Oncology Testing

1.2 Global Cancer Oncology Testing Market Size and Forecast

1.3 China Cancer Oncology Testing Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Cancer Oncology Testing Share in Global Market, 2019-2030

1.4.2 Cancer Oncology Testing Market Size: China VS Global, 2019-2030

1.5 Cancer Oncology Testing Market Dynamics

1.5.1 Cancer Oncology Testing Market Drivers

1.5.2 Cancer Oncology Testing Market Restraints

1.5.3 Cancer Oncology Testing Industry Trends

1.5.4 Cancer Oncology Testing Industry Policy

2 Global Competitive Situation by Company

2.1 Global Cancer Oncology Testing Revenue by Company (2019-2024)

2.2 Global Cancer Oncology Testing Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Cancer Oncology Testing Concentration Ratio

2.4 Global Cancer Oncology Testing Mergers & Acquisitions, Expansion Plans

2.5 Global Cancer Oncology Testing Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Cancer Oncology Testing Revenue by Company (2019-2024)

3.2 China Cancer Oncology Testing Cancer Oncology Testing Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Cancer Oncology Testing, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Cancer Oncology Testing Industry Chain

4.2 Cancer Oncology Testing Upstream Analysis

4.3 Cancer Oncology Testing Midstream Analysis

4.4 Cancer Oncology Testing Downstream Analysis

5 Sights by Type

5.1 Cancer Oncology Testing Classification

5.1.1 Fluorescence In Situ Hybridization

5.1.2 Polymerase Chain Reaction

5.1.3 Microarray Technology

5.1.4 Serum Proteomics

5.1.5 Nucleic Acid Sequencing

5.2 By Type, Global Cancer Oncology Testing Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Cancer Oncology Testing Revenue, 2019-2030

6 Sights by Application

6.1 Cancer Oncology Testing Segment by Application

6.1.1 Hospitals

6.1.2 Speciality Clinics

6.1.3 Research Institutes

6.1.4 Diagnostics Laboratories

6.1.5 Biopharmaceutical Companies

6.2 By Application, Global Cancer Oncology Testing Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Cancer Oncology Testing Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Cancer Oncology Testing Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Cancer Oncology Testing Market Size, 2019-2030

7.3 North America

7.3.1 North America Cancer Oncology Testing Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Cancer Oncology Testing Market Size Market Share

7.4 Europe

7.4.1 Europe Cancer Oncology Testing Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Cancer Oncology Testing Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Cancer Oncology Testing Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Cancer Oncology Testing Market Size Market Share

7.6 South America

7.6.1 South America Cancer Oncology Testing Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Cancer Oncology Testing Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Cancer Oncology Testing Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Cancer Oncology Testing Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Cancer Oncology Testing Market Size, 2019-2030

8.3.2 By Company, U.S. Cancer Oncology Testing Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Cancer Oncology Testing Market Size, 2019-2030

8.4.2 By Company, Europe Cancer Oncology Testing Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Cancer Oncology Testing Market Size, 2019-2030

8.5.2 By Company, China Cancer Oncology Testing Revenue Market Share, 2019-2024

8.5.3 By Type, China Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Cancer Oncology Testing Market Size, 2019-2030

8.6.2 By Company, Japan Cancer Oncology Testing Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Cancer Oncology Testing Market Size, 2019-2030

8.7.2 By Company, South Korea Cancer Oncology Testing Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Cancer Oncology Testing Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Cancer Oncology Testing Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Cancer Oncology Testing Market Size, 2019-2030

8.9.2 By Company, India Cancer Oncology Testing Revenue Market Share, 2019-2024

8.9.3 By Type, India Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Cancer Oncology Testing Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Cancer Oncology Testing Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Cancer Oncology Testing Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 Devyser

9.1.1 Devyser Company Information, Head Office, Market Area and Industry Position

9.1.2 Devyser Company Profile and Main Business

9.1.3 Devyser Cancer Oncology Testing Models, Specifications and Application

9.1.4 Devyser Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.1.5 Devyser Recent Developments

9.2 Agendia

9.2.1 Agendia Company Information, Head Office, Market Area and Industry Position

9.2.2 Agendia Company Profile and Main Business

9.2.3 Agendia Cancer Oncology Testing Models, Specifications and Application

9.2.4 Agendia Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.2.5 Agendia Recent Developments

9.3 Illumina

9.3.1 Illumina Company Information, Head Office, Market Area and Industry Position

9.3.2 Illumina Company Profile and Main Business

9.3.3 Illumina Cancer Oncology Testing Models, Specifications and Application

9.3.4 Illumina Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.3.5 Illumina Recent Developments

9.4 Personal Genome Diagnostics

9.4.1 Personal Genome Diagnostics Company Information, Head Office, Market Area and Industry Position

9.4.2 Personal Genome Diagnostics Company Profile and Main Business

9.4.3 Personal Genome Diagnostics Cancer Oncology Testing Models, Specifications and Application

9.4.4 Personal Genome Diagnostics Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.4.5 Personal Genome Diagnostics Recent Developments

9.5 Veracyte

9.5.1 Veracyte Company Information, Head Office, Market Area and Industry Position

9.5.2 Veracyte Company Profile and Main Business

9.5.3 Veracyte Cancer Oncology Testing Models, Specifications and Application

9.5.4 Veracyte Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.5.5 Veracyte Recent Developments

9.6 Pacific Biosciences of California

9.6.1 Pacific Biosciences of California Company Information, Head Office, Market Area and Industry Position

9.6.2 Pacific Biosciences of California Company Profile and Main Business

9.6.3 Pacific Biosciences of California Cancer Oncology Testing Models, Specifications and Application

9.6.4 Pacific Biosciences of California Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.6.5 Pacific Biosciences of California Recent Developments

9.7 Qiagen

9.7.1 Qiagen Company Information, Head Office, Market Area and Industry Position

9.7.2 Qiagen Company Profile and Main Business

9.7.3 Qiagen Cancer Oncology Testing Models, Specifications and Application

9.7.4 Qiagen Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.7.5 Qiagen Recent Developments

9.8 Agilent Technologies

9.8.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position

9.8.2 Agilent Technologies Company Profile and Main Business

9.8.3 Agilent Technologies Cancer Oncology Testing Models, Specifications and Application

9.8.4 Agilent Technologies Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.8.5 Agilent Technologies Recent Developments

9.9 Natera

9.9.1 Natera Company Information, Head Office, Market Area and Industry Position

9.9.2 Natera Company Profile and Main Business

9.9.3 Natera Cancer Oncology Testing Models, Specifications and Application

9.9.4 Natera Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.9.5 Natera Recent Developments

9.10 Bio Rad Laboratories

9.10.1 Bio Rad Laboratories Company Information, Head Office, Market Area and Industry Position

9.10.2 Bio Rad Laboratories Company Profile and Main Business

9.10.3 Bio Rad Laboratories Cancer Oncology Testing Models, Specifications and Application

9.10.4 Bio Rad Laboratories Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.10.5 Bio Rad Laboratories Recent Developments

9.11 Myriad Genetics

9.11.1 Myriad Genetics Company Information, Head Office, Market Area and Industry Position

9.11.2 Myriad Genetics Company Profile and Main Business

9.11.3 Myriad Genetics Cancer Oncology Testing Models, Specifications and Application

9.11.4 Myriad Genetics Cancer Oncology Testing Revenue and Gross Margin, 2019-2024

9.11.5 Myriad Genetics Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Cancer Oncology Testing Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Cancer Oncology Testing Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What is the estimated size & growth rate of the Cancer Oncology Testing Market?
In recent years, the Cancer Oncology Testing Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
In the current situation, what value does the Cancer Oncology Testing Market have?
The value of the Cancer Oncology Testing Market is estimated to be USD XXX million.
Who should consider the Cancer Oncology Testing Market study?
The Cancer Oncology Testing Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.